Lanean...
Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity
Doxorubicin (DOX) is one of the most widely used anticancer agents. DOX is known for inducing cardiotoxicity, resulting in the long-term development of heart failure. Intravascular delivery of DOX may benefit from the carriage by red blood cells (RBCs), as they can limit the systemic toxicity while...
Gorde:
| Argitaratua izan da: | Drug Deliv |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6450495/ https://ncbi.nlm.nih.gov/pubmed/30929538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2019.1591544 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|